APD 405Alternative Names: APD405
Latest Information Update: 17 Dec 2009
At a glance
- Originator Acacia Pharma
- Class Antiemetics
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Postoperative nausea and vomiting
Most Recent Events
- 17 Dec 2009 Discontinued - Phase-II for Postoperative nausea and vomiting in USA (IV)
- 17 Dec 2009 Discontinued - Phase-II for Postoperative nausea and vomiting in Europe (IV)